New England Ophthalmological Society, Inc.

September 11, 2015 Conference

Back to the Future: The NEW and OLD in Glaucoma

Visual field Interpretation: How is the test? Is it worse?
Angela Turalba

Gonioscopy: Still “State of the Art” 100 Years After Salzmann’s First Look
M. Wallace Alward

Molecular Genetics of Glaucoma: So What?
M. Wallace Alward

Glaucoma Medical Treatment- tailoring treatment to the patient's needs
Paul Cotran

Assessing Progression in Glaucoma
Michael Koval

Glaucoma Surgery: Which Procedure, When, and Why
Babak Eliassi-Rad

Glaucoma Risk Assessment
Susan Liang

Glaucoma Technology Update: OCT and the Pipeline for Glaucoma Devices
Teresa C. Chen

Pharmacology

Anti-Inflammatory Pharmacology
Shiyoung Roh

Pharmacology of Glues and Sealants
Michael B. Raizman

Targeting conventional outflow: Disease modifying glaucoma therapeutics
Dan Stamer

Drug Delivery – Glaucoma Treatment in Development
Steve Simmons

Formulation and Preservatives in Eye Drops
Michael Pokabla

Pharmacology of Ocular Surface Disease Therapy
Helen K. Wu

Pharmacology of anti-infective therapy
Jessica Chow

Pharmacology of current glaucoma therapy
Kimberly Miller

New England Ophthalmological Society, Inc. P.O. Box 549127, Waltham, MA 02451 - neos-eyes@mms.org - www.neos-eyes.org

Conference Management Software by X-CD Technologies Inc.

Conference Management Software by X-CD Technologies Inc.